[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PH22471A - Acetyl erythromycin stearate and compositions containing it - Google Patents

Acetyl erythromycin stearate and compositions containing it

Info

Publication number
PH22471A
PH22471A PH31689A PH31689A PH22471A PH 22471 A PH22471 A PH 22471A PH 31689 A PH31689 A PH 31689A PH 31689 A PH31689 A PH 31689A PH 22471 A PH22471 A PH 22471A
Authority
PH
Philippines
Prior art keywords
compositions containing
erythromycin stearate
acetyl erythromycin
acetyl
stearate
Prior art date
Application number
PH31689A
Other languages
English (en)
Inventor
Martti L A Marvola
Esko V Martilla
Jaakko A Uotila
Aino K Pipuri
Pekka J Kairisalo
Erkki J Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of PH22471A publication Critical patent/PH22471A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
PH31689A 1984-01-06 1985-01-07 Acetyl erythromycin stearate and compositions containing it PH22471A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
PH22471A true PH22471A (en) 1988-09-12

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
PH31689A PH22471A (en) 1984-01-06 1985-01-07 Acetyl erythromycin stearate and compositions containing it

Country Status (38)

Country Link
US (1) US4599326A (da)
JP (1) JPS60158197A (da)
KR (1) KR900006237B1 (da)
AT (1) AT386414B (da)
AU (1) AU565688B2 (da)
BE (1) BE901411A (da)
BG (1) BG43189A3 (da)
CA (1) CA1224461A (da)
CH (1) CH666275A5 (da)
CS (1) CS247191B2 (da)
CY (1) CY1462A (da)
DE (1) DE3500179A1 (da)
DK (1) DK149776C (da)
ES (1) ES8605818A1 (da)
FI (1) FI77249C (da)
FR (1) FR2557878B1 (da)
GB (1) GB2152502B (da)
HK (1) HK11590A (da)
HU (1) HU196221B (da)
IE (1) IE57967B1 (da)
IL (1) IL73885A (da)
IS (1) IS2968A7 (da)
IT (1) IT1184304B (da)
KE (1) KE3841A (da)
LU (1) LU85721A1 (da)
MA (1) MA20316A1 (da)
MX (1) MX156277A (da)
NL (1) NL8403979A (da)
NO (1) NO160263C (da)
NZ (1) NZ210606A (da)
PH (1) PH22471A (da)
PL (1) PL144349B1 (da)
PT (1) PT79777B (da)
RO (1) RO91262B (da)
SE (1) SE461854B (da)
SU (1) SU1410866A3 (da)
YU (1) YU44485B (da)
ZA (1) ZA8410143B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US7399488B2 (en) * 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2005041928A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for ehnanced absorption of iron
PT1765292T (pt) 2004-06-12 2017-12-29 Collegium Pharmaceutical Inc Formulações de fármacos dissuasoras de abuso
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
CA2714867A1 (en) 2006-06-23 2007-12-27 Candace B. Pert Non-aggregated pharmaceutically active peptide
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2836573C (en) 2011-05-18 2022-06-07 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
AU2013347975B2 (en) 2012-11-20 2018-07-26 Mederis Diabetes, Llc Improved peptide pharmaceuticals for insulin resistance
EP2922877B1 (en) 2012-11-20 2018-09-05 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
WO2015184177A1 (en) 2014-05-28 2015-12-03 Mederis Diabetes, Llc Improved peptide pharmaceuticals for insulin resistance
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
RU2019142102A (ru) * 2017-05-19 2021-06-21 Лунелла Байотек, Инк. Антимитосцины: направленные ингибиторы митохондриального биогенеза для эрадикации злокачественных стволовых клеток
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
KR102375232B1 (ko) 2018-02-06 2022-03-16 이지스 쎄라퓨틱스, 엘엘씨 비강내 에피네프린 제제 및 질환의 치료 방법
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
BR112021011963A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para alvejamento de mitocôndria e exterminação de células-tronco de câncer
AU2019402099A1 (en) * 2018-12-17 2021-07-08 Lunella Biotech, Inc. Triple combination therapies for anti-aging

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
HU196221B (en) 1988-10-28
SU1410866A3 (ru) 1988-07-15
FI77249B (fi) 1988-10-31
IE57967B1 (en) 1993-06-02
NO160263C (no) 1989-03-29
DK5884A (da) 1985-07-07
NZ210606A (en) 1987-08-31
GB8432368D0 (en) 1985-02-06
AU565688B2 (en) 1987-09-24
NL8403979A (nl) 1985-08-01
PT79777B (en) 1986-10-21
FI77249C (fi) 1989-02-10
IS2968A7 (is) 1985-04-03
PT79777A (en) 1985-01-01
GB2152502A (en) 1985-08-07
DK149776C (da) 1987-04-21
HUT37628A (en) 1986-01-23
YU2085A (en) 1987-12-31
ES539349A0 (es) 1986-04-01
MX156277A (es) 1988-08-04
YU44485B (en) 1990-08-31
IL73885A (en) 1988-10-31
DE3500179A1 (de) 1985-07-18
KR850005452A (ko) 1985-08-26
MA20316A1 (fr) 1985-10-01
FR2557878B1 (fr) 1988-01-15
AU3705984A (en) 1985-07-11
KR900006237B1 (ko) 1990-08-27
PL144349B1 (en) 1988-05-31
NO160263B (no) 1988-12-19
CA1224461A (en) 1987-07-21
DE3500179C2 (da) 1989-08-24
HK11590A (en) 1990-02-23
AT386414B (de) 1988-08-25
CY1462A (en) 1989-07-21
BG43189A3 (en) 1988-04-15
IE850022L (en) 1985-07-06
DK5884D0 (da) 1984-01-06
FI850023L (fi) 1985-07-07
DK149776B (da) 1986-09-29
RO91262B (ro) 1987-07-01
SE8406671D0 (sv) 1984-12-28
ZA8410143B (en) 1985-08-28
NO850007L (no) 1985-07-08
RO91262A (ro) 1987-06-30
KE3841A (en) 1989-04-07
SE461854B (sv) 1990-04-02
BE901411A (fr) 1985-04-16
LU85721A1 (fr) 1985-07-24
ES8605818A1 (es) 1986-04-01
IT8519012A0 (it) 1985-01-04
IT1184304B (it) 1987-10-28
GB2152502B (en) 1987-10-07
CH666275A5 (de) 1988-07-15
ATA985A (de) 1988-01-15
JPS60158197A (ja) 1985-08-19
FR2557878A1 (fr) 1985-07-12
SE8406671L (sv) 1985-07-07
FI850023A0 (fi) 1985-01-03
PL251457A1 (en) 1985-11-05
CS247191B2 (en) 1986-12-18
US4599326A (en) 1986-07-08
IL73885A0 (en) 1985-03-31
JPH029040B2 (da) 1990-02-28

Similar Documents

Publication Publication Date Title
PH22471A (en) Acetyl erythromycin stearate and compositions containing it
NZ213463A (en) Antibiotic compound and compositions
PH24830A (en) Indolize compounds and compositions containing them
GB2165751B (en) Pharmaceutical compositions containing anthracycline glycosides
IL74758A (en) Acyltripeptides and pharmaceutical compositions containing them
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
ZA892801B (en) Macrolide compositions
GB8401016D0 (en) Organopolysiloxane compositions
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
ZA859339B (en) Processes and compositions
EP0214102A3 (en) 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions
NZ211872A (en) Chartreusin derivatives and antitumorous compositions
AU519743B2 (en) Compositions containing erythromycin and metoclopramide
EP0230052A3 (en) Immunoamplifiers and related compositions
EP0210655A3 (en) Polystyrene compositions
GB8507503D0 (en) Acetyl compound
PH23343A (en) 8 0( acylaminoergolines and pharmaceutical compositions containing them
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
GB8514485D0 (en) Organopolysiloxane compositions
GB2205746B (en) Beta-glucuronidase containing compositions
NZ219645A (en) Pyrazoles and gametocidal compositions
GB8507710D0 (en) Acetyl compound
IE830409L (en) Oleandomycin and erythromycin derivatives
GB8500263D0 (en) 4'-deoxy-4'-halodoxorubicin-14-esters
IE842007L (en) Erythromycine and irosine compositions